Keio to conduct world's first iPS spinal stem cell transplant
Keio University's review committee endorses the world's first clinical trial of spinal cord treatment with iPS stem cells.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Keio University's review committee endorses the world's first clinical trial of spinal cord treatment with iPS stem cells.
© Nippon Television Network Corporation